The FDA has approved Tukysa (tucatinib) combined with trastuzumab and pertuzumab for the maintenance treatment of adult ...

Everyone should know their family history of breast cancer. But when it comes to risk factors for triple-negative breast cancer (TNBC), the stakes are higher for some women of color. TNBC is diagnosed ...

The World Health Organization reports that breast cancer was the most common form of the disease among women in 164 of 186 ...

WebMD awarded Huntsman Cancer Institute at the University of Utah (the U) its highest honor, the 2023 WebMD Elite Choice Award. While the WebMD Choice Awards were first announced in 2021, the Elite ...